Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)
Clinical trial NCT05295459 · COMPLETED
Trial details
- NCT number
- NCT05295459
- Sponsor
- Lyra Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2025-04-02
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.